INTRODUCTION: Although randomized trials demonstrate a benefit to surgical stabilization of rib fractures (SSRF), SSRF is rarely performed. We hypothesized older patients were less likely to receive SSRF nationally. METHODS: The 2016 National Inpatient Sample was used to identify adults with flail chest. Comorbidities and receipt of SSRF were categorized by ICD-10 code. Univariable testing and Multivariable regression were performed to determine the association of demographic characteristics and comorbidities to receipt of SSRF. RESULTS: 1021 patients with flail chest were identified, including 244 (23.9%) who received SSRF. Patients ≥70 years were less likely to receive SSRF. (<70 yrs 201/774 [26.0%] vs ≥70 43/247 [17.4%], P = .006) and had higher risk of death (<70 yrs 39/774 [5.0%] vs ≥70 33/247 [13.4%], P < .001) In multivariable modeling, only age ≥70 years was associated with SSRF (OR .591, P = .005). CONCLUSION: Despite guideline-based support of SSRF in flail chest, SSRF is performed in <25% of patients. Age ≥70 years is associated with lower rate of SSRF and higher risk of death. Future study should examine barriers to SSRF in older patients.
INTRODUCTION: Although randomized trials demonstrate a benefit to surgical stabilization of rib fractures (SSRF), SSRF is rarely performed. We hypothesized older patients were less likely to receive SSRF nationally. METHODS: The 2016 National Inpatient Sample was used to identify adults with flail chest. Comorbidities and receipt of SSRF were categorized by ICD-10 code. Univariable testing and Multivariable regression were performed to determine the association of demographic characteristics and comorbidities to receipt of SSRF. RESULTS: 1021 patients with flail chest were identified, including 244 (23.9%) who received SSRF. Patients ≥70 years were less likely to receive SSRF. (<70 yrs 201/774 [26.0%] vs ≥70 43/247 [17.4%], P = .006) and had higher risk of death (<70 yrs 39/774 [5.0%] vs ≥70 33/247 [13.4%], P < .001) In multivariable modeling, only age ≥70 years was associated with SSRF (OR .591, P = .005). CONCLUSION: Despite guideline-based support of SSRF in flail chest, SSRF is performed in <25% of patients. Age ≥70 years is associated with lower rate of SSRF and higher risk of death. Future study should examine barriers to SSRF in older patients.
Entities:
Keywords:
flail chest; increasing age; surgical stabilization of rib fractures
Authors: Stanislaw P Stawicki; Michael D Grossman; Brian A Hoey; Donna L Miller; James F Reed Journal: J Am Geriatr Soc Date: 2004-05 Impact factor: 5.562
Authors: Om P Sharma; Michael F Oswanski; Shashank Jolly; Sherry K Lauer; Rhonda Dressel; Heather A Stombaugh Journal: Am Surg Date: 2008-04 Impact factor: 0.688
Authors: John B Holcomb; Neil R McMullin; Rosemary A Kozar; Marjorie H Lygas; Frederick A Moore Journal: J Am Coll Surg Date: 2003-04 Impact factor: 6.113
Authors: Eric Bergeron; Andre Lavoie; David Clas; Lynne Moore; Sebastien Ratte; Stephane Tetreault; Jacques Lemaire; Marcel Martin Journal: J Trauma Date: 2003-03
Authors: Christopher J Tignanelli; Alexander Rix; Lena M Napolitano; Mark R Hemmila; Sisi Ma; Erich Kummerfeld Journal: JAMA Netw Open Date: 2020-03-02